Once‐a‐Day Controlled‐Release Dosage Form of Divalproex Sodium II: Development of a Predictive In Vitro Drug Release Method-Reference-Cited by-同舟云学术

Once‐a‐Day Controlled‐Release Dosage Form of Divalproex Sodium II: Development of a Predictive In Vitro Drug Release Method

Published:2003-11 Issue:11 Volume:92 Page:2317-2325
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Qiu Yihong,Garren J.,Samara E.,Cao G.,Abraham C.,Cheskin H.S.,Engh K.R.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference15 articles.

1. Depakote® Tablet. 2002. Physicians' desk reference.

2. Once‐a‐day controlled‐release dosage form of divalproex sodium I: Formulation design and in vitro/in vivo investigations;Qiu;J Pharm Sci,2003

3. Food and Drug Administration. 1997. Guidance for industry, extended release oral dosage forms: Development, evaluation, and application of in vitro/in vivo correlations.

4. Reserach and development aspects of oral controlled‐release dosage forms;Qiu,2000

5. The development of USP dissolution and drug release standards;Cohen;Pharm Res,1990

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro ‐ In Vivo Correlations of Pharmaceutical Dosage Forms;Oral Bioavailability and Drug Delivery;2023-10-10

2. Challenges and Unique Applications of IVIVC in Drug Development;Pharmaceutical Dissolution Testing, Bioavailability, and Bioequivalence;2022-01-07

3. Matrix Tablet Containing Quaternary Inclusion Complex of Domperidone for Treatment of Diabetic Gastroparesis;Indian Journal of Pharmaceutical Education and Research;2017-12-30

4. Product and Process Development of Solid Oral Dosage Forms;Developing Solid Oral Dosage Forms;2017

5. In Vitro/In Vivo Correlations;Developing Solid Oral Dosage Forms;2017